Another systematic review on immunity and inflammatory biomarkers in COVID19 (Iwamura et al., 2021), demonstrated low counts of CD3+ and CD4+ T cells and lymphocytes, especially in severe and critical COVID19 patients, while an erythrocyte sedimentation rate (ESR), CRP and IL6 were elevated, independent of the severity of disease. The gene discussed is CRP; the disease is COVID-19.